BLT2 是癌症进展过程中的促肿瘤发生介质，也是开发抗癌药物的治疗靶点。
BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development.
机构信息
College of Life Sciences and Biotechnology, Korea University Seoul 136-701, Korea.
出版信息
Am J Cancer Res. 2013 Aug 14;3(4):347-55. eCollection 2013.
Abstract
Cancer is a leading cause of death worldwide and has been linked to inflammation. Leukotriene B4 (LTB4) is synthesized from arachidonic acid via the 5-lipoxygenase pathway and is a potent chemoattractant for inflammatory cells. LTB4 was recently shown to be associated with the pathogenesis of inflammatory diseases, including cancer. Of the two known LTB4 receptors, BLT1 and BLT2, the biological roles of the low-affinity LTB4 receptor 2, BLT2, have only recently been elucidated. This review focuses on recent discoveries regarding BLT2 and its roles in cancer progression and the downstream signaling mechanisms of the BLT2-linked signaling cascade in cancer cells. We believe that these findings will facilitate the development of new cancer treatments.
摘要
癌症是全球主要死因之一，与炎症有关。白三烯 B4（LTB4）是通过 5-脂氧合酶途径从花生四烯酸合成的，是炎症细胞的有效趋化因子。最近的研究表明，LTB4 与炎症性疾病的发病机制有关，包括癌症。在两种已知的 LTB4 受体 BLT1 和 BLT2 中，低亲和力 LTB4 受体 2（BLT2）的生物学作用最近才被阐明。本综述重点介绍了 BLT2 的最新发现及其在癌症进展中的作用，以及癌症细胞中 BLT2 相关信号级联的下游信号机制。我们相信这些发现将有助于开发新的癌症治疗方法。
相似文献
1
BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development.
Am J Cancer Res. 2013 Aug 14;3(4):347-55. eCollection 2013.
2
Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Cardiovasc Res. 2009 Jan 1;81(1):216-25. doi: 10.1093/cvr/cvn277. Epub 2008 Oct 13.
3
A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung.
Expert Rev Respir Med. 2014 Aug;8(4):381-3. doi: 10.1586/17476348.2014.908715. Epub 2014 Apr 18.
4
Therapeutic target of leukotriene B receptors, BLT1 and BLT2: Insights from basic research.
Biochimie. 2023 Dec;215:60-68. doi: 10.1016/j.biochi.2023.06.014. Epub 2023 Jul 7.
5
Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.
J Immunol. 2006 Sep 1;177(5):3439-47. doi: 10.4049/jimmunol.177.5.3439.
6
Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway.
Carcinogenesis. 2010 Apr;31(4):543-51. doi: 10.1093/carcin/bgp203. Epub 2009 Sep 11.
7
Recent advances in function and structure of two leukotriene B receptors: BLT1 and BLT2.
Biochem Pharmacol. 2022 Sep;203:115178. doi: 10.1016/j.bcp.2022.115178. Epub 2022 Jul 16.
8
Leukotriene B receptors as therapeutic targets for ophthalmic diseases.
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158756. doi: 10.1016/j.bbalip.2020.158756. Epub 2020 Jun 11.
9
Macrophage LTB drives efficient phagocytosis of via BLT1 or BLT2.
J Lipid Res. 2017 Mar;58(3):494-503. doi: 10.1194/jlr.M068882. Epub 2017 Jan 4.
10
Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes.
J Biol Chem. 2005 Jul 1;280(26):24816-23. doi: 10.1074/jbc.M413257200. Epub 2005 May 2.
引用本文的文献
1
Arachidonic acid in aging: New roles for old players.
J Adv Res. 2025 Apr;70:79-101. doi: 10.1016/j.jare.2024.05.003. Epub 2024 May 4.
2
Two distinct forms of human BLT2: long-form and short-form BLT2.
Front Cell Dev Biol. 2023 Oct 26;11:1288373. doi: 10.3389/fcell.2023.1288373. eCollection 2023.
3
The Role and Regulation of Thromboxane A Signaling in Cancer-Trojan Horses and Misdirection.
Molecules. 2022 Sep 22;27(19):6234. doi: 10.3390/molecules27196234.
4
Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
Invest New Drugs. 2022 Apr;40(2):232-244. doi: 10.1007/s10637-021-01174-7. Epub 2021 Oct 11.
5
Elucidation of Mechanism for Ligand Efficacy at Leukotriene B Receptor 2 (BLT2).
ACS Med Chem Lett. 2020 Jul 14;11(8):1529-1534. doi: 10.1021/acsmedchemlett.0c00065. eCollection 2020 Aug 13.
6
The yin and yang of leukotriene B mediated inflammation in cancer.
Semin Immunol. 2017 Oct;33:58-64. doi: 10.1016/j.smim.2017.09.005. Epub 2017 Oct 2.
7
Neutrophils support lung colonization of metastasis-initiating breast cancer cells.
Nature. 2015 Dec 17;528(7582):413-7. doi: 10.1038/nature16140. Epub 2015 Dec 9.
8
Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3564-73. doi: 10.1073/pnas.1507905112. Epub 2015 Jun 23.
本文引用的文献
1
Eosinophil recruitment and activation: the role of lipid mediators.
Front Pharmacol. 2013 Mar 22;4:27. doi: 10.3389/fphar.2013.00027. eCollection 2013.
2
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
3
BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cells.
PLoS One. 2012;7(11):e49186. doi: 10.1371/journal.pone.0049186. Epub 2012 Nov 7.
4
The leukotrienes: immune-modulating lipid mediators of disease.
Adv Immunol. 2012;116:51-92. doi: 10.1016/B978-0-12-394300-2.00002-8.
5
Novel involvement of leukotriene B₄ receptor 2 through ERK activation by PP2A down-regulation in leukotriene B₄-induced keratin phosphorylation and reorganization of pancreatic cancer cells.
Biochim Biophys Acta. 2012 Dec;1823(12):2120-9. doi: 10.1016/j.bbamcr.2012.09.004. Epub 2012 Sep 24.
6
LTB4 is a signal-relay molecule during neutrophil chemotaxis.
Dev Cell. 2012 May 15;22(5):1079-91. doi: 10.1016/j.devcel.2012.02.003. Epub 2012 Apr 26.
7
Lipoxygenases: potential starting biocatalysts for the synthesis of signaling compounds.
Biotechnol Adv. 2012 Nov-Dec;30(6):1524-32. doi: 10.1016/j.biotechadv.2012.04.004. Epub 2012 Apr 17.
8
NF-κB and the link between inflammation and cancer.
Immunol Rev. 2012 Mar;246(1):379-400. doi: 10.1111/j.1600-065X.2012.01099.x.
9
Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.
Biochem Biophys Res Commun. 2012 Apr 6;420(2):428-33. doi: 10.1016/j.bbrc.2012.03.012. Epub 2012 Mar 9.
10
Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2.
J Biol Chem. 2012 Apr 20;287(17):13840-9. doi: 10.1074/jbc.M111.317131. Epub 2012 Mar 6.
Zotero 插件